A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma için istatistikler
Toplam ziyaret
| views | |
|---|---|
| A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
| Haziran 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Artificial-intelligence-in-reproductive-endocrinology-an-indepth-longitudinal-analysis-of-ChatGPTv4s-monthbymonth-interpretation-and-adherence-to-clinical-guidelines-for-diminished-ovarian-reserveEndocrine.pdf | 13 |
